Driehaus Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

A detailed history of Driehaus Capital Management LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 4,595,721 shares of XENE stock, worth $177 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

4,595,721

Previous 4,419,472 3.99%

Holding current value

$177 Million

Previous $172 Million 4.95%

% of portfolio

1.77%

Previous 1.86%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $6.37 Million - $7.75 Million	176,249 Added 3.99%	4,595,721 $181 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $3.54 Million - $4.28 Million	97,732 Added 2.26%	4,419,472 $172 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $999,950 - $1.17 Million	-23,440 Reduced 0.54%	4,321,740 $186 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $4.82 Million - $7.8 Million	-167,825 Reduced 3.72%	4,345,180 $200 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $8.47 Million - $9.85 Million	-247,848 Reduced 5.21%	4,513,005 $154 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $3.69 Million - $4.61 Million	105,928 Added 2.28%	4,760,853 $183 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $899,137 - $1.08 Million	-26,872 Reduced 0.57%	4,654,925 $167 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $5.88 Million - $7.01 Million	177,777 Added 3.95%	4,681,797 $185 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $3.48 Million - $4.5 Million	112,982 Added 2.57%	4,504,020 $163 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $27.7 Million - $38.3 Million	1,090,611 Added 33.04%	4,391,038 $134 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $4.45 Million - $5.87 Million	177,198 Added 5.67%	3,300,427 $101 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $25.1 Million - $57.1 Million	1,611,686 Added 106.63%	3,123,229 $97.6 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $8.42 Million - $11 Million	566,408 Added 59.93%	1,511,543 $23.1 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $2.92 Million - $3.47 Million	173,725 Added 22.52%	945,135 $17.6 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $4.45 Million - $6.95 Million	325,966 Added 73.18%	771,410 $13.8 Million
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $55,639 - $94,042	-5,863 Reduced 1.3%	445,444 $6.85 Million
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $139,859 - $172,562	-12,926 Reduced 2.78%	451,307 $5 Million
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $19,409 - $28,324	1,901 Added 0.41%	464,233 $5.82 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $3.74 Million - $8.12 Million	462,332 New	462,332 $5.24 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History